HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast.
CONCLUSION: The HALFMOON approach is technically feasible and resulted in high-dose conformity of the target with a significant reduction of radiation dose delivered to implant and other organs. A clinical study is needed to assess the impact on reconstruction cosmetic outcome and local control.
PMID: 31144158 [PubMed - indexed for MEDLINE]
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Leonardi MC, Spoto R, Miglietta E, Trivellato S, La Rocca E, Luraschi R, Grosso P, De Lorenzi F, Fodor C, Dicuonzo S, Dell'Acqua V, Gerardi MA, Morra A, Francia CM, Rietjens M, Galimberti VE, Veronesi P, Orecchia R, Cattani F, Jereczek-Fossa BA Tags: J Cancer Res Clin Oncol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Mastectomy | Prostate Cancer | Radiation Therapy | Skin | Statistics | Study